Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 18 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
Greenland Mines Ltd. (NASDAQ: GRML) Advances World-Class Palladium Deposit with Major Resource Upgrade
The combination of a structurally concentrated supply base, rising geopolitical risk from the dominant Russian…
-
Regentis Biomaterials Ltd. (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3 Billion Cartilage Repair Market
Regentis is targeting an estimated $3 billion U.S. cartilage repair market opportunity, supported by approximately…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Is Building a Modern Public Safety Platform by Integrating Tools, Training and Policy
Wrap Technologies treats non-lethal response as a system rather than a single device, integrating tools,…